Jun 05, 2023 / 11:00PM GMT
Operator
Welcome to the Merck & Co., Inc. investor event at the American Society of Clinical Oncology annual meeting. (Operator Instructions) This call is being recorded. If you have any objections, you may disconnect at this time.
I would now like to turn the call over to Mr. Peter Dannenbaum, Vice President and Investor Relations of Merck. Sir, you may begin.
Peter Dannenbaum - Merck & Co., Inc. - VP of IR
Thank you, Holly, and good evening, everyone. Welcome to Merck's investor event here at the American Society of Clinical Oncology annual meeting. Thank you to all of you who have made the effort to be here with us live, and thank you to everyone tuning in via the webcast. We're obviously very excited to have this opportunity to speak to you about Merck's oncology program.
During today's call, a slide presentation will accompany our speakers' prepared remarks. It's been posted to the Investor Relations section of our website. And before we get started, we'd like to remind you that some of the statements that we make during today's call may
Merck & Co Inc Investor Event at ASCO 2023 Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers